Secnidazole is a nitroimidazole antibiotic used to treat bacterial vaginosis. Secnidazole is a second-generation 5-nitroimidazole antimicrobial agent.
- Mechanism
- Curator reviewed · 3 references
Like other 5-nitroimidazole antimicrobials, the antimicrobial and antiprotozoal activity of secnidazole is accounted for by the nitro group in the imidazole ring. Upon entering the target pathogen, the nitro group of secnidazole is reduced by bacterial or parasitic nitroreductase enzymes, producing radical anions and reactive intermediates. Radical anions and reactive intermediates cause the depletion of thiols, DNA helix damage, disruption of bacterial or parasitic protein synthesis and replication, and ultimately, cell death of susceptible isolates of Gram positive bacteria, Gram negative bacteria and T. vaginalis.
- Primary indication
- Secnidazole is indicated for treating trichomoniasis and bacterial vaginosis in patients 12 years of age and older.Curator reviewed · 5 structured indications
- Formula / weight
- C7H11N3O3 · 185.183 g/mol (avg)
- First approval
- United States, 2017
- Code names
- PM-185184 · RP-14539 · SYM-1219
- Brand names
Resolves to
KPQZUUQMTUIKBP-UHFFFAOYSA-NSMILESCC(O)CN1C(C)=NC=C1N(=O)=OWhat you can answer from here — as of September 23, 2026
Which other approved drugs treat the same conditions as Secnidazole, and which companies have late-stage candidates in those indications?
Create a free account or log in to explore the full data card.
Create Account